Shenzhen Neptunus Bioengineering Company Description

Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, infusion products, and western medicine preparations in China.

The company provides oryzanol tablets, chlorpheniramine tablets, chlorpheniramine maleate tablets, and rifampicin capsules, as well as technical support for generic drug quality consistency evaluation and other medical research and development work.

It also distributes drugs, medical devices, and other medical supplies; and provides value-added services for hospitals, medical institutions, and drug retail institutions and distributors.

The company offers drugs in the fields of malignant tumors, cardiovascular and cerebrovascular diseases, neurodegenerative diseases, diabetes, infectious diseases, and multiple diseases, such as respiratory system and digestive system.

Shenzhen Neptunus Bioengineering Co., Ltd. was founded in 1989 and is headquartered in Shenzhen, China.

Shenzhen Neptunus Bioengineering Co., Ltd.

Country	China
Founded	1989
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	8,264
CEO	Feng Zhang

Contact Details

Address: Neptunus Galaxy Technology Building Shenzhen, 518057 China
Phone	86 755 2698 0336
Website	neptunusbio.com

Stock Details

Ticker Symbol	000078
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE000000X95
SIC Code	5122

Key Executives

Name	Position
Feng Zhang	Vice Chairman of the Board and President
Da Kai Shen	Financial Director, Vice President and Director
Yi Fei Zhang	Executive Vice President and Director
Rui Jin	Vice President and Non-Independent Director
Xiao Peng Wang	Vice President
Shuangcheng Yang	Vice President
Xiaoming Shi	Vice President
Yunlei Wang	Vice President and Board Secretary
Ge Jin	Vice President